New Delhi: Lupin on Friday ... improvement in quality of life and other functional and clinical outcomes for patients. NaMuscla, which has been designated orphan drug status in Europe and US ...

As per the agreement, SUP will obtain regulatory approvals for selling Tiotropium DPI in China, while Lupin will be the ...

Lupin has signed a licence and supply agreement with SteinCares to commercialise its biosimilar ranibizumab in Latin American ...

The ruling blocks Lupin and Zydus Life from selling their generic version of Mirabegron, the bioequivalent of Astellas' overactive bladder drug, Myrbetriq, in the United States. According to the ...

Lupin partners with SUP to commercialize Tiotropium DPI in China, aiming to improve respiratory health with innovative products.

The drug is the generic equivalent of Supernus Pharmaceuticals’ Oxtellar XR and is used to treat partial-onset seizures in ...

“Cost Plus Drugs, Lupin and the COPD Foundation all share ... medications are a pathway to a healthier, more empowered life for COPD patients,” said Jean Wright, CEO of the COPD Foundation.

Johnson & Johnson and Indian drugmaker Lupin will supply their versions ... "This historic price reduction will broaden access to this life-saving drug and keep us on the path to end TB by 2030 ...

Aug 30 (Reuters) - Johnson & Johnson (JNJ.N), opens new tab and Indian drugmaker Lupin ... for drug-resistant TB infections. "This historic price reduction will broaden access to this life ...

Analysts expect Lupin to have gained from launch ramp-ups of drugs with limited competition ... business in India into a separate unit, Lupin Life Sciences. The business sells branded prescription ...

2025 /PRNewswire/ -- Nanomi B.V., a Dutch subsidiary of the global pharma major Lupin Limited, today announced that it has won the prestigious CMO Award for Life Science Leadership in Drug ...

Waning said her and her colleagues have already coordinated with two Indian manufacturers, Lupin and Macleods, to produce the drug, and the organization will soon be accepting bids and selecting a ...